Leo CEO Bourdon Plots Return To Profit This Year

As Early-Stage R&D Is Axed

 
• By Kevin Grogan
Christophe Bourdon
Christophe Bourdon • Source: Leo Pharma

More from Dermatological

More from Therapeutic Category